Literature DB >> 7769469

Improvements in preventive care and communication for deaf patients: results of a novel primary health care program.

T G MacKinney1, D Walters, G L Bird, A B Nattinger.   

Abstract

OBJECTIVE: To test the hypothesis that profoundly deaf persons would have better preventive care compliance and improved physician communication if enrolled in a primary care program providing American Sign Language (ASL) interpreters.
DESIGN: A case-cohort community-based study. The authors had ASL-fluent research assistants interview 90 randomly selected patients (the cases) enrolled in a unique primary care program for the deaf (Deaf Services Program), which provided full-time ASL interpreters and subsidized health care costs for some patients. Eighty-five deaf controls were friends of the cases drawn from the community.
RESULTS: The cases were poorer and less often married than were the controls, but other baseline characteristics were similar. The cases were more likely (p < 0.05) to report receiving within the preceding three years Pap tests (90% vs 72%), mammography (86% vs 53%), and rectal examinations (72% vs 25%), but not breast examinations (76% vs 71%, p = 0.7). The cases were more likely than the controls to report receiving counseling in ASL for psychiatric and substance abuse problems (49% vs 5%, p < 0.001). Although only 18% of the controls were fluent in written English, 67% of them used written notes to communicate with their physicians. Twenty percent of the controls used ASL interpreters compared with 84% of the cases (p < 0.001). More cases than controls were moderately or extremely satisfied with communication with their physicians (92% vs 42%, p < 0.001).
CONCLUSION: Deaf persons enrolled in a primary care program that included full-time interpreters were more likely to use ASL, were more satisfied with physician communications, and had improved preventive care outcomes.

Entities:  

Mesh:

Year:  1995        PMID: 7769469     DOI: 10.1007/BF02599667

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  8 in total

1.  Selection of controls in case-control studies. I. Principles.

Authors:  S Wacholder; J K McLaughlin; D T Silverman; J S Mandel
Journal:  Am J Epidemiol       Date:  1992-05-01       Impact factor: 4.897

2.  Who has Pap tests? Variables associated with the use of Pap tests in absence of screening programmes.

Authors:  G Ronco; N Segnan; A Ponti
Journal:  Int J Epidemiol       Date:  1991-06       Impact factor: 7.196

3.  A comparison of the health knowledge of hearing-impaired and hearing high school students.

Authors:  D Kleinig; H Mohay
Journal:  Am Ann Deaf       Date:  1990-07

4.  Accuracy of women's self-report of their last Pap smear.

Authors:  J A Sawyer; J A Earp; R H Fletcher; F F Daye; T M Wynn
Journal:  Am J Public Health       Date:  1989-08       Impact factor: 9.308

5.  Medical interpreting for hearing-impaired patients.

Authors:  G Reisman; J Scanlan; K Kemp
Journal:  JAMA       Date:  1977-05-30       Impact factor: 56.272

6.  Health knowledge, attitudes, and practices of the deaf population in greater New Orleans--a pilot study.

Authors:  L G Lass; R R Franklin; W E Bertrand; J Baker
Journal:  Am Ann Deaf       Date:  1978-12

7.  A comparison of physician and patient reports of Pap smear histories.

Authors:  S D Walter; E A Clarke; J Hatcher; L W Stitt
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

8.  Screening mammography: a missed clinical opportunity? Results of the NCI Breast Cancer Screening Consortium and National Health Interview Survey Studies.

Authors: 
Journal:  JAMA       Date:  1990-07-04       Impact factor: 56.272

  8 in total
  16 in total

1.  Communicating with Patients with Disability: Perspectives of Practicing Physicians.

Authors:  Nicole Agaronnik; Eric G Campbell; Julie Ressalam; Lisa I Iezzoni
Journal:  J Gen Intern Med       Date:  2019-03-18       Impact factor: 5.128

2.  Impact of communication on preventive services among deaf American Sign Language users.

Authors:  Michael M McKee; Steve L Barnett; Robert C Block; Thomas A Pearson
Journal:  Am J Prev Med       Date:  2011-07       Impact factor: 5.043

3.  Effectiveness of videos improving cancer prevention knowledge in people with profound hearing loss.

Authors:  Philip Zazove; Helen E Meador; Barbara D Reed; Ananda Sen; Daniel W Gorenflo
Journal:  J Cancer Educ       Date:  2012-06       Impact factor: 2.037

4.  Health literacy and the disenfranchised: the importance of collaboration between limited English proficiency and health literacy researchers.

Authors:  Michael M McKee; Michael K Paasche-Orlow
Journal:  J Health Commun       Date:  2012

5.  Health care system accessibility. Experiences and perceptions of deaf people.

Authors:  Annie G Steinberg; Steven Barnett; Helen E Meador; Erin A Wiggins; Philip Zazove
Journal:  J Gen Intern Med       Date:  2006-03       Impact factor: 5.128

6.  Cancer prevention knowledge of people with profound hearing loss.

Authors:  Philip Zazove; Helen E Meador; Barbara D Reed; Ananda Sen; Daniel W Gorenflo
Journal:  J Gen Intern Med       Date:  2009-01-09       Impact factor: 5.128

7.  Breast cancer knowledge and practices among D/deaf women.

Authors:  Barbara A Berman; Angela Jo; William G Cumberland; Heidi Booth; Jon Britt; Carolyn Stern; Philip Zazove; Gary Kaufman; Georgia Robins Sadler; Roshan Bastani
Journal:  Disabil Health J       Date:  2013-06-30       Impact factor: 2.554

Review 8.  [Deaf patients in psychiatry].

Authors:  Matthäus Fellinger; Johannes Fellinger
Journal:  Neuropsychiatr       Date:  2013-11-22

9.  Palliative and end-of-life care in Newfoundland's deaf community.

Authors:  Victor Maddalena; Fiona O'Shea; Myles Murphy
Journal:  J Palliat Care       Date:  2012       Impact factor: 2.250

10.  Can you hear me now? The experience of a deaf family member surrounding the death of loved ones.

Authors:  Karen A Kehl; Constance M Gartner
Journal:  Palliat Med       Date:  2009-11-12       Impact factor: 4.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.